Dear Colleagues, Friends & Fraternity Members,

Thank you for enjoying the last two editions of Best of ASCO Hong Kong. In these challenging times, we are committed to providing the highest quality of care to our patients and keeping ourselves updated with the latest advances in cancer care.

It is our pleasure to announce that the Hong Kong International Oncology Research Society (HKIORS) and the American Society of Clinical Oncology (ASCO) are partnering together this year to bring Best of ASCO 2024, Hong Kong on 31st August'24 in Hong Kong at Hotel Cordis, Hong Kong. Together with HKIORS, we aim to bring you a Highly-interactive conference on practice-changing clinical data in oncology this year.

As you are aware, Best of ASCO is a very popular program run by ASCO in over twenty-five countries. This program has the latest and best scientific studies in clinical oncology (which will be presented at the ASCO Annual Conference 2024) handpicked by the scientific committee members of the Hong Kong & ASCO team and showcased to doctors.

Our scientific committee will cover up to 24 topics on Thoracic, Breast, Gastrointestinal, Urological, Gynaecological, and Lymphoma Oncology with an impactful plenary session in between.

The one-day program will be a great opportunity to attend lectures focused on different aspects of oncology, in-person panel discussions with experts, and the latest technologies displayed physically by world-class pharmaceuticals and medical companies.

We look forward to welcoming you and a wide audience of clinical oncologists, medical oncologists, hematologists, and other medical specialists as well as trainees in addition to other healthcare professionals like nurses and pharmacists, to join the sessions to review the latest research and explore new therapies and their potential impact on cancer care in Hong Kong.

Please register at special rates and keep abreast of the latest trends in clinical oncology. We look forward to a great scientific conference with all of you.

Regards,
Hong Kong International Oncology Research Society (HKIORS)